05.24.21 Eli Lilly Weighs The Benefits & Challenges Of Head-To-Head Trials
This report provides data on 240 service provider encounters with 18 electronic clinical outcome assessment/electronic patient reported outcomes (eCOA/ePRO) systems. eCOA/ePRO providers: Learn how your company performs against competitors. Discover where performance exceeds expectations so you can differentiate your offerings from competitors. For sponsors/CROs: Compare your company’s outsourcing philosophy to that of the broader industry. Evaluate your provider selection process. Explore new providers and understand how they have performed for industry peers.
Clinical Leader
In this webinar segment, Tero Laulajainen, VP and head of global clinical science and operations for UCB, and Hassan Kadhim, global head of clinical trial business capabilities, clinical innovation, and industry collaborations at Bristol-Myers Squibb, discuss the guidance issued by regulato
Avoid Critical Findings In Your TMF - A Review Of MHRA Findings
By Gillian Gittens, Director of eClinical Strategy and Solutions, TransPerfect, Trial Interactive
In clinical research, there is great emphasis on the TMF being inspection-ready at all times. However, regulatory agencies still encounter critical findings in the TMF during inspection. The MHRA recently published their annual GCP Inspections Metrics Report covering metrics from April 1, 2018, to March 31, 2019, which include what issues were found during inspections. In this white paper, we take a look at the most common TMF issues and how to avoid them.
Signing up provides unlimited access to: